Sort by
Refine Your Search
-
and innovation (R&I) ecosystem. This is a unique opportunity to establish or expand your research programme in the UK, collaborate with world-class researchers, and contribute to national and global
-
involve expanding our work on Dual-Function Reagents (see Angew. Chem. Int. Ed. 2023, 62, e202218371). You will join a creative group focused on designing new reagents and methods in an exciting area in
-
a team, customer service skills across any industry could well be an advantage. The department uses multiple computer systems to deliver its services therefore experience using multiple systems is
-
methods (statistics, ML, AI) with applications to energy and built environment problems and programming languages e.g. Python, R, Matlab, C# etc applied at highlighted scales. About you We welcome
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in
-
of Southampton is hosting and other similar events. You will also engage with staff at the School of Electronics and Computer Science (ECS) from a range of ECS groups and ECS centres, who themselves have exciting
-
or more of: the use of micro/nanofabrication and materials characterization tools; computational multi-physics/electromagnetics modelling and/or the application of machine learning algorithms; experimental
-
(or be close to completing one) with strong quantitative and computational skills in high-performance computing environments. Your expertise should be in one or more of the following areas: hydrological
-
work experience, preferably within an NHS hospital healthcare setting. A full induction & orientation programme is provided. The role requires a weekday work pattern and is funded for 25 hours per week
-
research program is dedicated to the development of novel antibody-based therapeutics for the treatment of cancer and autoimmunity. This research has led to several therapeutics that are currently in